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Multifunctional adapter and chaperone protein Daxx participates in the regulation of a number of mainly
transcription-related processes. Most notably in a complex with chromatin-remodelling ATPase ATRX,
Daxx serves as a histone H3.3 chaperone at telomeric regions and certain genes. In this report we
document that Daxx interacts with another chromatin-remodelling, ATPase Brg1. We conﬁrm the Daxx-
Brg1 association both in vitro and in cells and show that Daxx interacts with Brg1 in high-molecular-
weight complexes. Ectopic co-expression of Daxx with Brg1 and PML could shift disperse nuclear loca-
lisation of Brg1 into PML bodies. Mapping the Daxx-Brg1 interaction revealed that Daxx preferentially
binds the region between Brg1 N-terminal QLQ and HSA domains, but also weakly interacts with its
C-terminal part. Brg1 interacted with both the central and N-terminal parts of Daxx. SiRNA-mediated
down-regulation of Daxx in SW13 adrenal carcinoma cells markedly enhanced expression of Brg1-ac-
tivated genes CD44 or SCEL, suggesting that Daxx either directly through Brg1 and/or indirectly via other
factors is a negative regulator of their transcription. Our ﬁndings point to Brg1 as another chromatin-
remodelling protein that might similarly, as ATRX, target Daxx to speciﬁc chromatin regions where it can
carry out its chromatin- and transcription-regulating functions.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Death-domain associated protein 6 (Daxx) is a multifunctional,
promyelotic leukaemia (PML)-interacting adapter protein, which is
vital for mouse embryogenesis [1,2] and participates in many
processes including apoptosis, protein stability and regulation of
transcription [3–7].
Being predominantly a transcriptional repressor, Daxx bridges
many transcription factors including nuclear factor –kB (NF-κB) or
nuclear receptors [8,9] to histone deacetylases, such as histone
deacetylase 2 (HDAC2), and thus mediates transcriptional repres-
sion of a number of genes [5]. Through its association with DNA
methyltransferase DNMT1, Daxx can enhance methylation and
thus transcriptional suppression of RelB target genes or the tu-
mour suppressor RASSF1A [4,10]. Daxx is also required for the
epigenetic silencing of the integrated retroviral DNA [11], or the
repression of human cytomegalovirus (HCMV) immediate-early
genes (IEG) [12].B.V. This is an open access article u
netics AS CR, Videnska 1083,
dera).The most recently revealed function of Daxx is connected with
chromatin remodelling, namely with the regulation of HIRA- and
the replication-independent deposition of the histone variant H3.3
[13–16]. Daxx, through interaction with the chromatin-remodel-
ling ATPase Alpha thalassaemia/mental retardation syndrome
X-linked (ATRX), mediates H3.3 deposition either at telomeres,
pericentromeric heterochromatin or in some actively transcribed
genes. Daxx interaction with chromatin- and PML-associated
protein DEK [17] is required for proper loading of H3.3 on the
telomeres [18] and the Daxx/ATRX complex, through interaction
with Suv39h methyltransferase suppresses via H3K9 trimethyla-
tion expression of a number of genes during mouse embryogen-
esis [19]. ATRX-Daxx-dependent reposition of the histone H3.3
variant is associated with repression of adenoviral or CMV pro-
moters [20,21], but interestingly during early EBV infection, te-
gument protein BNRF1 apparently replaces ATRX, and via repro-
gramming Daxx-mediated H3.3 loading thus allowing late gene
expression [22]. In contrast, ATRX-Daxx-mediated H3.3 loading
enhanced transcriptional activation of neural immediate early
genes Bdnf or Egr2 [23]. In addition to telomeres and transcribed
genes, Daxx also participates in the distribution of centromeric H3
variant CenH3 at centromers, which is connected with enhancednder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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uncovered that ATRX-Daxx-mediated H3.3 loading contributes to
the endogenous retroviral elements in embryonic stem cells [25].
ATRX-Daxx acts as a chaperone in anti-tumour protection – their
mutations were found in pancreatic neuroendocrine tumours and
paediatric glioblastomas and were associated with a more ag-
gressive phenotype and reduced survival [26–28]. The possible
ATRX-Daxx tumour suppressive function could be related to its
negative modulation of alternative lengthening of telomeres [29].
Brg1 and its sibling Brm belong, similarly as ATRX, to the family of
chromatin-remodelling ATPases. These evolutionarily conserved en-
zymes function in multiprotein complexes and participate in the
regulation of chromatin structure, inﬂuencing transcription, DNA
replication, DNA repair and other chromatin-related processes [30].
The importance of Brg1 is underscored by the fact that Brg1 null
mouse embryos die several days after implantation, as Brg1 regulates
the self-renewal potential of stem cells through the expression of the
core pluripotency-related genes [31,32]. Among other Brg1-regulated
genes are cytokine response genes, nuclear receptors, genes involved
in differentiation (e. g. homeotic genes, Wnt signalling pathway), cell
cycle modulation (regulated by p53, E2Fs and pRB) and many others
[33–36]. Brg1 is also involved in carcinogenesis both as a tumour
suppressor and as a tumour promoting gene [37].
In this report we aimed to get a better understanding of the
role and function of Daxx in cell physiology and we searched for
and analysed novel Daxx-interacting proteins. Among others we
found the chromatin-remodelling ATPase Brg1 as a novel Daxx-
interacting protein and analysed some functional consequences of
their interaction. Our data document that Daxx participates in the
transcriptional suppression of the expression of several Brg1-
regulated genes in SW13 cells. However, whether Daxx/Brg1 can
have wider functional consequences, such as H3.3 loading and
regulation of gene expression, remains to be investigated.2. Materials and methods
2.1. Cell cultures
SW13, HeLa and HEK293T cells (all ATCC) were cultivated in
DMEM, and supplemented with 10% FBS and antibiotics (peni-
cillinþstreptomycin). MCF10a (ATCC) cells were cultivated in
MCF10a medium (ATCC).
2.2. Plasmids and oligonucleotides
Lists of used plasmids and oligonucleotides are shown in Sup-
plementary Tables 1 and 2.
2.3. Antibodies
The following antibodies were used for western-blotting, im-
munoprecipitation and immunocytochemistry: Daxx02 and
Daxx03 (mouse IgG1s), anti-hDaxx pAbU (rabbit polyclonal anti-
body) – all produced in our laboratory; H-88 and G-7 (hBrg1), E-1
(hBrm), H-76 (hBAF155), TU-01 (α-tubulin) and C-11 (actin) – all
from Santa Cruz Biotechnologies; 1B1B2 (histone 3) – from Cell
Signalling Technology; M2 (FLAG epitope), 9E10 (Myc epitope)-both
from Sigma Aldrich, and AFP01 (α-fetoprotein, AFP) – mouse IgG1
kindly provided by V. Hořejší.
2.4. Yeast two-hybrid screening for proteins interacting with Daxx
1-595
The pGBKT7-Daxx 1-595 construct was used for screening a
HeLa cDNA library, cloned into the prey vector pGAD-GH (Clontech)for potential Daxx-interacting proteins. The screening and post-
screening analyses were carried out according to Matchmaker
3 Two-Hybrid System manual (Clontech).
2.5. Transient transfections
HEK293T cells were transfected using polyethylene imine
(Sigma Aldrich) according to [38]. SW13, HeLa cells were trans-
fected with GeneCellin (BioCellChallenge) and siRNA was trans-
fected into SW13 cells using Lipofectamine RNAiMAX (Invitrogen)
and the standard protocol (Life Technologies). Used siRNA: siDaxx
#1 (GGAGTTGGATCTCTCAGAA, according to [39]) and siDaxx
BþCþD (a mixture of siGENOME siRNAs from Dharmacon:
J-004420-07, J-004420-06, J-004420-05)
2.6. Puriﬁcation of recombinant protein and in vitro pulldown assay
Combined His6þGST-tagged Daxx and its variants were pro-
duced in E. coli BL21 (DE3) from pET42b-based expression plas-
mids and puriﬁed with TALON (Clontech) and Glutathion-Sephar-
ose beads (GE Healthcare). For the pull-down assays, these beads
were incubated with in vitro translated 35S-labelled Brg1, prepared
by TNT Quick Coupled Transcription/Translation kit (Promega)
using TRAN 35S Label (MP Radiochemicals). The bound proteins
were eluted with the sample buffer, subjected to SDS-electro-
phoresis and visualised on a Phosphor Imaging Plate in BAS 5000
instrument (FujiFilm).
2.7. Cell lysis and immunoprecipitation
In non-detergent lysis, the cellular pellets (50 million cells)
were resuspended in 3 volumes of hypotonic buffer (10 mM HEPES
pH 7.5, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT; EDTA-free Com-
plete protease inhibitors, Roche), incubated on ice, lysed by pushing
through a 25G needle and centrifuged (13,500 rpm, 30 s). The
supernatants (cytosolic extracts) were mixed with 1.5 volume of
hypertonic buffer (20 mM HEPES pH 7.5, 1.5 mM MgCl2, 420 mM
NaCl, 0.2 mM EDTA pH 8.0, 25% glycerol, 0.5 mM DTT; Complete).
The pellets (nuclei) were resuspended in 1.5 volume of hypertonic
buffer, shortly sonicated, incubated on ice for 30 min and cen-
trifuged ( 13,500 rpm, 10 min). These supernatants (nuclear ex-
tracts) were diluted 3-times with hypotonic buffer and both cyto-
solic and nuclear extracts were used for immunoprecipitations.
For the detergent lysis, the cellular pellets (7 million cells) were
resuspended in 3 volumes of lysis buffer (50 mM HEPES pH 7.5,
250 mM NaCl, 0,5% Nonidet P-40, 2% glycerol; Complete), shortly
sonicated, incubated at 4 °C for 30 min and centrifuged (13,500 rpm,
10 min). The supernatants were diluted with 1.5 volumes of water
containing 1.5 mM DTT and used for immunoprecipitations.
For the immunoprecipitations, the lysates were incubated with
3–5 μg of appropriate antibodies at 4 °C for 15 h, centrifuged
( 13,500 rpm, 10 min) and the immunocomplexes were pulled-
down by 50 μl of Protein A/G agarose beads (SC Biotechnologies) on
a rotation wheel at 4 °C for 90 min. After washing, the bound
proteins were eluted with the sample buffer, heat-denatured and
analysed by Western blotting.
2.8. Confocal microscopy
Transfected HeLa cells grown on glass cover-slips in a 24-wells
plate were ﬁxed with 3% paraformaldehyde in PBS for 20 min,
permeabilised with 0.5% Triton X-100 for 20 min and ﬁnally blocked
with 10% human serum in PBS for 1 h. These cells were incubated
with the primary antibodies and diluted in PBS for 1 h, then with
the secondary antibodies (goat-anti-mouse with conjugated Alexa
647 and goat-anti-rabbit with conjugated Rhodamine Red-X,
Fig. 1. Ectopically expressed Daxx interacts with Brg1 and Brm but not with SNF2H. HEK293T cells were transfected with Myc-Daxx FL or empty vector, together with empty
vector or FLAG-Brg1, FLAG-Brm and FLAG-SNF2H. The cell lysates were immunoprecipitated with either anti-Myc or anti-FLAG antibodies and analysed by Western blotting.
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with 1.25 μM DAPI for 5 min. The cover-slips were mounted on
slides in ProLong Gold anti-fade reagent (Invitrogen) and analysed
using a Leica TCS SP5 confocal microscope.2.9. Preparation of adenoviruses
Recombinant adenoviruses expressing either EGFP or EGFP-tagged
Brg1 (kindly provided by R. Bremner) were ampliﬁed in HEK293T
cells and puriﬁed by Adeno-X puriﬁcation kit (Clontech). Puriﬁed
adenoviruses were stored in aliquots in the storage buffer (1GTS,)
at 80 °C. One aliquot of each adenovirus was titrated and in the
experiments the recombinant adenoviruses were used at MOI¼1–2.3. Transfections, transductions, isolation of RNA, reverse
transcription, qRT-PCR and statistical analysis
SW13 cells grown on 12-wells plates were twice transfected
with siRNAs in two consecutive days using RNAiMax. Cells were
then transduced with 0.05, 0.1 or 0.15 μl of adenoviruses, ex-
pressing either EGFP or EGFP-Brg1. 48 h post-transduction, the
cells were lysed for both protein (SDS lysis buffer) and RNA
(RNeasy Plus Mini kit, QIAGEN) analyses. One μg of extracted total
RNA was reverse transcribed with RevertAid (Fermentas) and used
for quantitative real-time PCR (LightCycler 480 SYBR Green I
master-mix and LightCycler 480 instrument, Roche). The se-
quences of primers are shown in Supplementary Table 2. For the
statistical analysis in Fig. 4 we used paired Student's t-test.3.1. Gel ﬁltrations
HEK293T cells (3108) were lysed by “non-detergent lysis”,
the nuclear lysates were concentrated to 1.5 ml by ultraﬁltration
(Amicon Ultra 30 k, Millipore) and applied to a Superose 6 column
(GE Healthcare). Pooled fractions were divided into two parts: the
ﬁrst (1/3 of total volume) was concentrated on Microcon-10
(Millipore) to 15 μl, mixed with 15 μl of SDS-sample buffer and
analysed by Western blotting; the second part (2/3) was pooled
(inputs: fractions 2.-6. to input I., 7.–11. to input II., 12.-16. to input
III.), concentrated to 400 μl, and used for immunoprecipitations.4. Results
4.1. Daxx interacts with the chromatin-remodelling ATPase Brg1
both in vitro and in vivo.
Daxx interacts with a number of mainly nuclear proteins, pre-
dominantly through its C-terminal Ser/Pro/Thr-rich (SPT) region or
distal SUMO interacting motif (SIM) [40]. To exclude proteins that
interact with this promiscuous C-terminal part of Daxx, in our yeast
two hybrid (Y2H) screening for novel Daxx-interacting partners, we
used as bait the evolutionary and structurally conserved N-terminal
[41] and central part of Daxx (amino acids 1-595).The screening
provided 24 positive hits (mainly nuclear and chromatin-associated
proteins, including previously identiﬁed ATRX or DMAP1, see Sup-
plementary Table 3). Y2H re-screening for possible false interactors
narrowed down this selection to chromatin-remodelling ATPase
ATRX [42], then DMAP1 [43] and seven other proteins. All of these
seven novel putative interactors (BAP1, FEZ2, UBN1, SAP30, UXT,
BRG1 and ABRA1) co-immunoprecipitated with Daxx from the ly-
sates of co-transfected HEK293T cells (Supplementary Fig. 1). Having
in mind the important function of ATRX-Daxx as a novel chromatin-
remodelling H3.3 chaperone, we have chosen Brg1 as another
chromatin-remodelling ATPase for in detail analysis of its molecular
and functional interactions with Daxx.
Brg1 or the related Brm, but not unrelated ATPase SNF2H, were
co-immunoprecipitated with Daxx from the lysates of co-trans-
fected HEK293T cells (Fig. 1, lanes 8, 9 and 15, 16). Using two dif-
ferent anti-Daxx monoclonal antibodies, we also co-im-
munoprecipitated the endogenous Brg1 with Daxx from the nuclear
lysates of non-transfected HEK293T (Fig. 2a, lanes 6, 8; anti-alpha
fetoprotein, AFP antibody was used as non-speciﬁc control) or
MCF10A (Supplementary Fig. 2, lane 4) cells, indicating that their
interaction also occurs under physiological conditions. In addition
to Brg1, we also co-precipitated BAF155, a core member of Brg1-
containing chromatin-remodelling complexes (Fig. 2a), implying
that Daxx interacts with Brg1 bound in a complex. Indeed, the gel
ﬁltration analysis showed that a minor part of Daxx is found in
fractions containing high molecular weight complexes (1 MDa and
higher) (Fig. 2b, lanes 2–6) and only from these fractions is Brg1
efﬁciently co-immunoprecipitated with Daxx (Fig. 2c, pool I, lane 9).
A prominent partner among Daxx-interacting proteins is PML,
which shelters Daxx in PML nuclear bodies and could modulate
some of the functions of Daxx, such as H3.3 loading [18]. In
transfected HeLa cells we conﬁrmed that ectopically expres-
sed Daxx strongly associates with PML bodies, formed by both
Fig. 2. Endogenous Daxx and Brg1 interact in high molecular weight complexes. HEK293T cells were lysed by non-detergent lysis to separate cytoplasmic and nuclear
fractions: (a) immunoprecipitation of both cytoplasmic and nuclear fraction with anti-AFP and anti-Daxx (Daxx03 and Daxx02) antibodies, (b) gel ﬁltration of nuclear lysates
on Superose 6 column. Fractions from gel ﬁltration were pooled (fractions 2.–6. to mixture I., 7.–11. to II. and 12.–16. to III.), (c) immunoprecipitated with anti-AFP and anti-
Daxx (Daxx03) antibodies, and analysed by Western blotting.
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contrast, ectopically expressed Brg1 was diffused and did not bind
to any nuclear structure (Supplementary Fig. 3b). Co-expression of
Daxx or PML with Brg1, also did not largely enhance their asso-
ciation with PML bodies, although in some cells, Brg1/PML co-
expression led to weak association of Brg1 with PML bodies, likely
mediated by the endogenous Daxx (Supplementary Fig. 3c).
However, when all three proteins were expressed at a similar level
in transfected HeLa cells, we observed clear co-localization of all of
them in PML bodies (Supplementary Fig. 3d), indicating that a
signiﬁcant portion of co-transfected Daxx and Brg1 can interact,
and thus conﬁrming the co-immunoprecipitation data (Fig. 1 and
Supplementary Fig. 2).
4.2. Daxx interacts with Brg1 via at least two independent regions.
Having conﬁrmed the interaction between Daxx and Brg1 in
yeast and mammalian cells, we aimed to determine the interacting
regions in both proteins. We chose both in vitro (GST pull-down
assay) and in vivo (transient co-transfection of mammalian cells)
systems as a methodological approach. For the GST pull-down
assays we initially split GST-fused Daxx into three parts –
N-terminal, central and C-terminal (Fig. 3a) – and analysed, to-
gether with GST-Daxx full length (FL), their interaction with in
vitro translated Brg1. The pull-down assays ﬁrst of all revealed that
GST-Daxx FL can directly and reproducibly interact with the full-
length Brg1 (Fig. 3b, lane 1 vs. 2 – GST control). We also found that
mainly the central part of Daxx, but not its C-terminal SPE- and S/
P/T-containing domain strongly interacted with Brg1. However, wealso detected slightly weaker but still signiﬁcant interaction of
Brg1 with the N-terminal, DHB domain-containing part of Daxx
(Fig. 3b, lanes 3–5). These data were then conﬁrmed by co-im-
munoprecipitation of expressed Daxx FL or its three parts with co-
expressed Brg1 (Fig. 3c). Only Myc-tagged Daxx FL or its N-term-
inal and central parts but not the C-terminus could form com-
plexes with FLAG-tagged Brg1, that were pulled-down by either
anti-Myc or anti-FLAG antibodies (Fig. 3c, compare lanes 10–12
with 13 and 19–21 with 22). Using confocal microscopy of trans-
fected HeLa cells we conﬁrmed that the Daxx deletion variants are
localised in the nucleus (Supplementary Fig. 4a). In addition, co-
transfection of these deletion variants with Brg1 and PML also
conﬁrmed the co-immunoprecipitation data, and revealed that
both Brg1-interacting N-terminal (AAs 1-225) and central (AAs
225–503) fragments localise into PML bodies and pull Brg1 into
them, while the non-interacting C-terminal Daxx fragment (504–
740) does not (Supplementary Fig. 4b).
Next we aimed to narrow down the Daxx interaction region on
Brg1. The part of Brg1 pulled-down in the yeast two-hybrid
screening (clone #3) mapped to the N-terminus of Brg1, contain-
ing the HSA domain (Supplementary Fig. 5a). Co-expression of this
interaction region containing the N-terminal half of Brg1 with
Daxx FL in HEK293T cells followed by immunoprecipitation, in-
deed conﬁrmed that the Daxx-interacting domain resides in this
N-terminal part of Brg1 (Supplementary Fig. 5b, lanes 15 and 28).
However, Daxx apparently also co-immunoprecipitated with the
second, C-terminal half of Brg1 (Supplementary Fig. 5b, lanes 19
and 32). Thus, as for the Daxx itself, there are also at least two
regions mediating interaction between these two proteins. In the
Fig. 3. Brg1 interacts with the N-terminal and central parts of Daxx. (a) Human Daxx (SIM-SUMO interacting motif, DHB-Daxx homology bundle, SPE-Ser/Pro/Glu rich, SPT-
Ser/Pro/Thr rich) were divided into N-terminal (amino acids 1–224), central (amino acids 225–503) and C-terminal (amino acids 504–740) fragments. (b) GST-tagged Daxx
fragments GST-Daxx WT and GST tag alone were incubated with 35S-labelled Brg1 together with Glutathion-Sepharose 4B beads. After the SDS-PAGE, GST-tagged proteins
were visualised by Coomassie staining and 35S-labelled Brg1 by autoradiography. (c) HEK293T cells were transfected with FLAG-Brg1 FL or empty vector together with empty
vector or Myc-Daxx fragments and Myc-Daxx FL. The cell lysates were immunoprecipitated with either anti-Myc or anti-FLAG antibodies and analysed by Western blotting.
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mutants and examined their interaction with co-transfected Daxx
(Supplementary Fig. 5b, lanes 16–18 and 29–31). We were able to
narrow down the Daxx-interacting region to amino acids 358-430,
just N-terminally to the HSA domain (Supplementary Fig. 5b,
compare lanes 16 to 17 or 29 to 30). This part of Brg1 also belongs
to the phylogenetically most conserved parts of Brg1 (Supple-
mentary Fig. 5c).
4.3. Daxx negatively affects expression of Brg1-regulated genes in
SW13 cells.
Brg1, as a part of the Swi/Snf chromatin remodelling complex,
actively participates in the regulation of transcription of a number of
genes. As one of the important functions of Daxx is also the reg-
ulation of transcription, we focused on evaluating the Daxx role in
Brg1-dependent, transcription-related processes. SW13 adrenocor-
tical carcinoma cells lack the Brg1 expression and its re-introduction
into these cells leads to transactivation of a number of genes in-
cluding p21, CSF1, SPARC or CD44 [44]. Transduction of SW13 cells
with the Brg1-expressing adenovirus did increase the expression of
CD44, Sciellin (SCEL), SPARC or CSF1 in a dose-dependent manner
(Fig. 4 and not shown). SiRNA-mediated down-regulation of Daxx
expression prior to the transduction led to a boost of Brg1-mediated
expression of CD44 and SCEL, both at mRNA and protein levels
(Fig. 4). Intriguingly, Daxx downregulation also led to the suppres-
sion of Brg1 mRNA expression (Fig. 4b) but these changes were only
limitedly reﬂected in Brg1 protein expression (Fig. 4a). Nevertheless
despite apparently lower expression of Brg1 in siDaxx transfected
cells than in control cells, the expression of its targets CD44 and
SCEL signiﬁcantly increased. This Daxx down-regulation-mediated
enhancement of transcription was reproducible with several various
Daxx siRNA, and points to an inhibitory rather than activator role of
Daxx in transactivation of at least some of Brg1-dependent genes.5. Discussion
The so-far known Daxx transcription-related functions are
mainly repressive, mediated by bridging various chromatin-mod-
ifying factors, such as histone deacetylases or DNA-methyl-
transferases, to transcription regulatory regions [3]. Recently, Daxx
bound to chromatin-remodelling ATPase ATRX was also re-
cognised as a histone H3.3 chaperone, bringing H3.3 to telomeres
or some actively transcribed genes [13]. However, the proper cel-
lular role of Daxx, e.g. during the embryogenesis (Daxx knockout is
lethal at E9.5), still remains elusive.
In this study we point to Brg1, another chromatin-remodelling
ATPase with multiple roles in transcription and DNA repair [30], as a
novel Daxx-interacting partner. We identiﬁed their interaction in a
yeast two-hybrid screen and conﬁrmed it by multiple in vitro and
in vivo interaction assays, such as GST-pulldown or co-im-
munoprecipitation of both transfected and endogenous proteins.
Moreover, we also co-immunoprecipitated Daxx and Brg1 from gel
ﬁltration fractions containing high-molecular-weight complexes
(around 1–1.5 MDa) and, under some circumstances (co-expression of
Brg1, Daxx and PML), we also observed their co-localization in PML
bodies. Importantly, similar high molecular weight complexes and co-
localization in PML bodies were also shown for ATRX and its inter-
action with Daxx [42]. ATRX serves as a DNA-binding anchor, essen-
tial for Daxx-mediated positioning of histone H3.3 [13,45] and for
Daxx-mediated repression of CMV-promoter-regulated inducible
transgene array [20]. However, the ATRX-Daxx H3.3 loading complex
could also contribute to the activation of immediate early genes, such
as Bdnf, in activated murine neurons [23]. Our data support rather a
repressive role of Daxx in Brg1-dependent transcription of CD44 and
SCEL genes in adrenal carcinoma SW13 cells. These cells lack Brg1
expression and its re-introduction leads to enhanced transcription of
CD44 and several other genes. Our data document that siRNA-
mediated down-regulation of Daxx, greatly enhanced expression of
Fig. 4. Down-regulation of Daxx leads to up-regulation of Brg1-regulated CD44 and SCEL genes. SW13 cell line was transfected with siRNA (control, siDaxx #1 and siDaxx
BþCþD, a combination of three distinct siRNAs) and then infected with recombinant adenoviruses (0.05, 0.1 or 0.15 μl) expressing either EGFP or EGFP-tagged Brg1. The cells
were then subjected to both (a) Western blotting and (b) qRT-PCR analyses. The statistical signiﬁcance was assessed by paired Student's t-test.
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Daxx, possibly connected to histone deacetylases or its chaperone-like
function. This repressive impact of Daxx on the transcription of Brg1-
regulated genes might also be independent or only partly dependent
on its interaction with Brg1, and further experiments will be required
to elucidate the role of Daxx-Brg1 interaction in this process.
We also addressed and mapped the regions responsible for the
interaction between Daxx and Brg1. On Daxx, the interaction
surface is likely to be broad within its N-terminal and central re-
gions. Interestingly, previously found Daxx-interacting proteins
involved in the epigenetic regulation of ATRX and DMAP1 tran-
scription also interact with the N-terminal/central part of Daxx
[42,43,46], which is also the only region on Daxx, structured into
a-helical bundle domain [41]. The part of Brg1 to which we
mapped the major interaction with Daxx, i.e. the region between
QLQ and HSA domains, also mediates the interaction between Brg1
and BAF250a/ARID1A and it is apparently required for gluco-
corticoid receptor-dependent transactivation [47].
In summary, we identiﬁed chromatin remodelling ATPase Brg1
as a new Daxx-interacting protein and thus strengthened the Daxx
connection to the epigenetic regulation of transcription. As both
Brg1 and also recently Daxx, are being considered as tumour
suppressors, their presumable functional interaction might have
an impact on the regulation of chromatin status or gene expres-
sion in cancer cells and thus also affect tumour progression.Acknowledgements
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